Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2014; 20(13): 3534-3541
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3534
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3534
Figure 2 Schematic representation of different glutathione-S-transferase catalyzed phenomenons (blue boxes) that even through intermediate events (light blue) bring or contibute to the canonical mechanisms of action (yellow), determining the therapeutic effects (green) and/or adverse events (orange).
GSH: Reduced glutathione.
- Citation: Stocco G, Pelin M, Franca R, De Iudicibus S, Cuzzoni E, Favretto D, Martelossi S, Ventura A, Decorti G. Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? World J Gastroenterol 2014; 20(13): 3534-3541
- URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3534.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i13.3534